Together we will beat cancerDonate
Melanoma is a type of skin cancer that develops from cells called melanocytes. It’s the 5th most common cancer in the UK, with around 16,200 new cases of melanoma in the UK each year.
Vitamin D influences the behaviour of melanoma cells in the lab by making them less aggressive, Cancer Research UK scientists have found.
Melanoma skin cancer incidence rates have soared by 45% since 2004, according to the latest figures released by Cancer Research UK.
A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.
A new immunotherapy treatment for certain advanced skin cancer patients is to be made available on the NHS in England.
Melanoma patients with a history of smoking cigarettes are 40 per cent less likely to survive their skin cancer than people who have never smoked
Scientists have uncovered molecules released by invasive skin cancer that reprogram healthy immune cells to help the cancer to spread.
An immunotherapy drug will be made available to some patients with advanced melanoma skin cancer on the NHS in England.
Some patients with advanced skin cancer will now have access to immunotherapy after surgery on the NHS in England.
Patients with a certain type of aggressive skin cancer will now have access to a combination of targeted drugs on the NHS in England.
Scientists have discovered that testing skin cancer patients’ blood for tumour DNA could help predict the chances of an aggressive cancer returning.